Adc Therapeutics Sa (ADCT)

Apr 16, 2025

Antibody Drug Conjugate Market to Witness Upsurge in Growth - openPR.com

Apr 16, 2025

Apr 15, 2025

Wellington Management Group LLP Purchases 84,785 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World

Apr 15, 2025

Apr 13, 2025

ADC Therapeutics : Announces Eight Presentations on Data from its Next-Generation Antibody Drug Conjugates at the 62nd American Society of Hematology Annual Meeting - marketscreener.com

Apr 13, 2025

Apr 13, 2025

Sei Investments Co. Invests $46,000 in ADC Therapeutics SA (NYSE:ADCT) - The AM Reporter

Apr 13, 2025

Apr 13, 2025

Sei Investments Co. Makes New $46,000 Investment in ADC Therapeutics SA (NYSE:ADCT) - Defense World

Apr 13, 2025

Apr 12, 2025

Prudential Financial Inc. Invests $35,000 in ADC Therapeutics SA (NYSE:ADCT) - Defense World

Apr 12, 2025

Apr 09, 2025

Neuroendocrine tumors Pipeline Analysis and Clinical Trials - openPR.com

Apr 09, 2025

Apr 09, 2025

SEC Form PRE 14A filed by ADC Therapeutics SA - Quantisnow

Apr 09, 2025

Apr 08, 2025

HC Wainwright Lifts Earnings Estimates for ADC Therapeutics - MarketBeat

Apr 08, 2025

Apr 08, 2025

ADC Therapeutics : 24th Annual Needham Virtual Healthcare Conference - MarketScreener

Apr 08, 2025

Apr 07, 2025

Analyzing Ratios: Adc Therapeutics SA (ADCT)’s Financial Story Unveiled - DWinneX

Apr 07, 2025

Apr 07, 2025

ADC Therapeutics SA (NYSE:ADCT) Sees Large Decline in Short Interest - MarketBeat

Apr 07, 2025

Apr 04, 2025

Research Analysts Set Expectations for ADCT Q1 Earnings - Defense World

Apr 04, 2025

Apr 04, 2025

Burkitt Lymphoma Market Expected to Witness Significant Growth by 2032 | DelveInsight - The Globe and Mail

Apr 04, 2025

Apr 04, 2025

ADC Therapeutics SA's (NYSE:ADCT) 31% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st

Apr 04, 2025

Apr 04, 2025

NBE Therapeutics opens ADC research facility in Switzerland - Pharmaceutical Technology

Apr 04, 2025

Apr 04, 2025

Guggenheim Has Lowered Expectations for ADC Therapeutics (NYSE:ADCT) Stock Price - MarketBeat

Apr 04, 2025

Apr 03, 2025

ADC Therapeutics' (ADCT) Buy Rating Reiterated at HC Wainwright - MarketBeat

Apr 03, 2025

Apr 03, 2025

ADCT Stock Touches 52-Week Low at $1.61 Amid Market Challenges - MSN

Apr 03, 2025

Apr 02, 2025

ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Malaysian Reserve

Apr 02, 2025

Apr 01, 2025

ADC Therapeutics (NYSE:ADCT) Announces Quarterly Earnings Results - MarketBeat

Apr 01, 2025

Apr 01, 2025

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PR Newswire

Apr 01, 2025

Apr 01, 2025

ADC Therapeutics (NYSE:ADCT) Given “Buy” Rating at HC Wainwright - Defense World

Apr 01, 2025

Apr 01, 2025

ADC Therapeutics (NYSE:ADCT) Price Target Lowered to $7.00 at Guggenheim - Defense World

Apr 01, 2025

Mar 31, 2025

ADC Therapeutics SA (ADCT) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

Guggenheim cuts ADC Therapeutics target to $7, keeps Buy rating By Investing.com - Investing.com UK

Mar 31, 2025

Mar 29, 2025

Bank of New York Mellon Corp Buys 9,750 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World

Mar 29, 2025

Mar 29, 2025

ADC Therapeutics SA (NYSE:ADCT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025

Mar 28, 2025

Earnings call transcript: ADC Therapeutics Q4 2024 beats EPS, misses revenue - Investing.com Australia

Mar 28, 2025

Mar 28, 2025

ADC Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Mar 28, 2025

Mar 28, 2025

RBC Capital maintains Outperform on ADC Therapeutics stock By Investing.com - Investing.com UK

Mar 28, 2025

Mar 27, 2025

ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 27, 2025

Mar 27, 2025

ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update - StreetInsider.com

Mar 27, 2025

Mar 27, 2025

ADC Therapeutics targets $600M–$1B in peak ZYNLONTA revenue amid expansion into DLBCL market - MSN

Mar 27, 2025

Mar 27, 2025

ADC Therapeutics SA reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025

Mar 27, 2025

ADC Therapeutics Q4 Net Income USD -30.727 Million - MarketScreener

Mar 27, 2025

Mar 27, 2025

ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Finan - GuruFocus

Mar 27, 2025

Mar 27, 2025

ADC Therapeutics reports Q4 results, beats on EPS but misses revenue By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

ADC Therapeutics reports Q4 results, beats on EPS but misses revenue - Investing.com

Mar 27, 2025

Mar 27, 2025

ADC THERAPEUTICS SA -REDH Earnings Results: $ADCT Reports Quarterly Earnings - Nasdaq

Mar 27, 2025

Mar 26, 2025

A Preview Of ADC Therapeutics's Earnings - Benzinga

Mar 26, 2025

Mar 25, 2025

ADC Therapeutics Announces Abstracts Accepted for Presentation a - GuruFocus

Mar 25, 2025

Mar 25, 2025

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 - StreetInsider

Mar 25, 2025

Mar 25, 2025

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 – Company Announcement - Financial Times

Mar 25, 2025

Mar 25, 2025

ADC Therapeutics: Promise Remains, But Fortunes Rest On Success Of Single Trial In 2025 - Seeking Alpha

Mar 25, 2025

Mar 23, 2025

ADC Therapeutics SA (NYSE:ADCT) Shares Bought by Platinum Investment Management Ltd. - MarketBeat

Mar 23, 2025